Stem Cell Therapy for Heart Failure

In a report published at Express in April 2013, Mayo Clinic researchers used special stem cells collected from the patient's hip to treat patients with heart failure. Proteins are used to direct stem cells to function as cardiac cells and then inject them into the patient's heart. Although the results show that the patient's health has improved significantly, this technology still requires further research to determine that the cause of the hip stem cells may cause this effect.

Stem cell therapy for heart disease contributes to cardiomyocyte production, secretion of growth factors, promotion of new healthy blood vessel growth, and other kinds of help. Stem cell therapy uses autologous bone marrow stem cells and "adipose derived" stem cells. Stem cell therapy provides "erythropoiesis" ex vivo and uses hematopoietic cells (HSC) for this purpose. HSC is a precursor of erythrocytes. We have created an experimental environment simulating the bone marrow environment and added a growth factor called erythropoietin that enables cells to grow adequately

Stem cell therapy uses stem cells to treat or prevent certain medical conditions. Stem cells are found only in multicellular organisms including humans. An undifferentiated stem cell mass grows by a growth process known as cell division and mitosis and differentiates into specialized cells. The most widely practiced form of stem cell therapy is bone marrow transplantation in which donor bone marrow stem cells are transplanted into cancer patients with conditions such as lymphoma and leukemia. During cancer treatment, almost all of the growing cells of the patient's body are destroyed by the cytotoxic agent used during treatment. Donor provides his / her healthy bone marrow cells. And it can replace cells that were killed or destroyed in the patient (cells lost by the patient during chemotherapy)

As of January 2016, 10 cell therapies are approved worldwide, but the only stem cell therapy that is widely used is bone marrow transplantation. Hematopoietic stem cells in the bone marrow are the first confirmed stem cells, the first stem cells used clinically. This life saving technique has helped thousands of people around the world with blood cancers such as leukemia. There is no way to predict when the first human embryonic stem cell therapy will be widely used. Several applications from the US Food and Drug Administration for human testing of embryonic stem cell based therapies have been approved. Generally, the way from the first human trial to being widely used is about 10 years. This long period is the result of many steps that must be experienced in therapy to prove that it is safe and effective. Only after completing these procedures will the FDA approve treatment for general use.